herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 145, 472-477. Hall, C. B., Caserta, M. T., Schnabel, K. C., Long, C., Epstein, L. G., Insel, R. A. & Dewhurst, S. (1998). Persistence of human herpesvirus 6 according to site and variant: possib<strong>le</strong> greater neurotropism of variant A. Clin Infect Dis 26, 132-137. Hall, C. B., Long, C. E., Schnabel, K. C., Caserta, M. T., McIntyre, K. M., Costanzo, M. A., Knott, A., Dewhurst, S., Insel, R. A. & Epstein, L. G. (1994). Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 331, 432-438. Haruda, F. (1979). Phenytoin hypersensitivity: 38 cases. Neurology 29, 1480-1485. Hashimoto, K., Yasukawa, M. & Tohyama, M. (2003). Human herpesvirus 6 and drug al<strong>le</strong>rgy. Curr Opin Al<strong>le</strong>rgy Clin Immunol 3, 255-260. Hashizume, H., Takigawa, M. & Tokura, Y. (2002). Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol 168, 5359-5368. Hernan<strong>de</strong>z-Losa, J., Fe<strong>de</strong><strong>le</strong>, C. G., Pozo, F., Tenorio, A., Fernan<strong>de</strong>z, V., Castellvi, J., Parada, C. & Ramon y Cajal, S. (2005). Lack of association of polyomavirus and herpesvirus <strong>type</strong>s 6 and 7 in human lymphomas. Cancer 103, 293-298. Hinz, M., Lemke, P., Anagnostopoulos, I., Hacker, C., Krappmann, D., Mathas, S., Dorken, B., Zenke, M., Stein, H. & Schei<strong>de</strong>reit, C. (2002). Nuc<strong>le</strong>ar factor kappaB-<strong>de</strong>pen<strong>de</strong>nt gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196, 605-617. Hjalgrim, H., Rostgaard, K., Johnson, P. C., Lake, A., Shield, L., Litt<strong>le</strong>, A. M., Ekstrom- Smedby, K., Adami, H. O., Glimelius, B., Hamilton-Dutoit, S., Kane, E., Taylor, G. M., McConnachie, A., Ry<strong>de</strong>r, L. P., Sundstrom, C., An<strong>de</strong>rsen, P. S., Chang, E. T., A<strong>le</strong>xan<strong>de</strong>r, F. E., Melbye, M. & Jarrett, R. F. HLA-A al<strong>le</strong><strong>le</strong>s and infectious mononuc<strong>le</strong>osis suggest a critical ro<strong>le</strong> for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A 107, 6400-6405. Hock, B. D., Haring, L. F., Steinkasserer, A., Taylor, K. G., Patton, W. N. & McKenzie, J. L. (2004). The solub<strong>le</strong> form of CD83 is present at e<strong>le</strong>vated <strong>le</strong>vels in a number of hematological malignancies. Leuk Res 28, 237-241. Houwerzijl, J., De Gast, G. C., Nater, J. P., Esselink, M. T. & Nieweg, H. O. (1977). Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity. Clin Exp Immunol 29, 272-277. Hu, M., Krause, D., Greaves, M., Sharkis, S., Dexter, M., Heyworth, C. & Enver, T. (1997). Multilineage gene expression prece<strong>de</strong>s commitment in the hemopoietic system. Genes Dev 11, 774-785. Huang, X., van <strong>de</strong>n Berg, A., Gao, Z., Visser, L., Nolte, I., Vos, H., Hepkema, B., Kooistra, W., Poppema, S. & Diepstra, A. Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients. PLoS One 5, e10865. Hubacek, P., Maalouf, J., Zajickova, M., Kouba, M., Cinek, O., Hyncicova, K., Fa<strong>le</strong>s, I. & Cetkovsky, P. (2007). Failure of multip<strong>le</strong> antivirals to affect high HHV-6 DNAaemia resulting from viral chromosomal integration in case of severe aplastic anaemia. Haematologica 92, e98-e100. Hubacek, P., Muzikova, K., Hrdlickova, A., Cinek, O., Hyncicova, K., Hrstkova, H., Sedlacek, P. & Stary, J. (2009a). Preva<strong>le</strong>nce of HHV-6 integrated chromosomally among children treated for acute lymphoblastic or myeloid <strong>le</strong>ukemia in the Czech Republic. J Med Virol 81, 258-263. 168
Hubacek, P., Virgili, A., Ward, K. N., Pohlreich, D., Keslova, P., Goldova, B., Markova, M., Zajac, M., Cinek, O., Nacheva, E. P., Sedlacek, P. & Cetkovsky, P. (2009b). HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis. Br J Haematol 145, 394-398. Ichimi, R., Jin-no, T. & Ito, M. (1999). Induction of apoptosis in cord blood lymphocytes by HHV-6. J Med Virol 58, 63-68. Inaoka, M. (2005). Innate immunity and hypersensitivity syndrome. Toxicology 209, 161-163. Inoue, Y., Yasukawa, M. & Fujita, S. (1997). Induction of T-cell apoptosis by human herpesvirus 6. J Virol 71, 3751-3759. Irsch, J., Wolf, J., Tesch, H., Diehl, V., Radbruch, A. & Staratschek-Jox, A. (2001). Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease-<strong>de</strong>rived cell lines. Br J Haematol 113, 785-793. Isegawa, Y., Hara, J., Amo, K., Osugi, Y., Takemoto, M., Yamanishi, K., Fukunaga, R., Shibata, M., Ohshima, A., Horiguchi, Y. & Sugimoto, N. (2009). Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the <strong>de</strong>ath of an allogeneic stem cell transplant recipient. J Clin Virol 44, 15-19. Isegawa, Y., Mukai, T., Nakano, K., Kagawa, M., Chen, J., Mori, Y., Sunagawa, T., Kawanishi, K., Sashihara, J., Hata, A., Zou, P., Kosuge, H. & Yamanishi, K. (1999). Comparison of the comp<strong>le</strong>te DNA sequences of human herpesvirus 6 variants A and B. J Virol 73, 8053-8063. Iyengar, S., Levine, P. H., Ablashi, D., Neequaye, J. & Pearson, G. R. (1991). Seroepi<strong>de</strong>miological investigations on human herpesvirus 6 (HHV-6) infections using a newly <strong>de</strong>veloped early antigen assay. Int J Cancer 49, 551-557. Jarrett, R. F., G<strong>le</strong>dhill, S., Qureshi, F., Crae, S. H., Madhok, R., Brown, I., Evans, I., Krajewski, A., O'Brien, C. J., Cartwright, R. A. & et al. (1988). I<strong>de</strong>ntification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia 2, 496-502. Jeulin, H., Salmon, A., Gautheret-Dejean, A., Agut, H., Bordigoni, P., Fortier, B. & Venard, V. (2009). Contribution of human herpesvirus 6 (HHV-6) viral load in who<strong>le</strong> blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation. J Clin Virol 45, 43-46. Joos, S., Kupper, M., Ohl, S., von Bonin, F., Mechtersheimer, G., Bentz, M., Marynen, P., Mol<strong>le</strong>r, P., Pfreundschuh, M., Trumper, L. & Lichter, P. (2000). Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 60, 549-552. Josephs, S. F., Salahuddin, S. Z., Ablashi, D. V., Schachter, F., Wong-Staal, F. & Gallo, R. C. (1986). Genomic analysis of the human B-lymphotropic virus (HBLV). Science 234, 601-603. Jundt, F., Acikgoz, O., Kwon, S. H., Schwarzer, R., Anagnostopoulos, I., Wiesner, B., Mathas, S., Hummel, M., Stein, H., Reichardt, H. M. & Dorken, B. (2008). Aberrant expression of Notch1 interferes with the B-lymphoid pheno<strong>type</strong> of neoplastic B cells in classical Hodgkin lymphoma. Leukemia 22, 1587-1594. Jundt, F., Anagnostopoulos, I., Forster, R., Mathas, S., Stein, H. & Dorken, B. (2002). Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 99, 3398-3403. Jungnickel, B., Staratschek-Jox, A., Brauninger, A., Spieker, T., Wolf, J., Diehl, V., Hansmann, M. L., Rajewsky, K. & Kuppers, R. (2000). Clonal <strong>de</strong><strong>le</strong>terious mutations 169
- Page 1:
UNIVERSITE DE LIMOGES ECOLE DOCTORA
- Page 4 and 5:
Sommaire Liste des figures p.7 List
- Page 6 and 7:
VI.2. Nouvelles approches p.71 Trav
- Page 8 and 9:
Liste des tableaux Tableau 1 Caract
- Page 10 and 11:
IE immediate early Ig immunoglobuli
- Page 12 and 13:
Sous-famille Virus Alphaherpesvirin
- Page 14 and 15:
Environnement bibliographique Parti
- Page 16 and 17:
II.2. Génome Le génome d’HHV-6
- Page 18 and 19:
U2-U19 U27-U37 U38-U40 U41-U46 U48-
- Page 20 and 21:
sont détectés environ 3h après l
- Page 22 and 23:
IV.4. Encapsidation Les signaux sp
- Page 24 and 25:
V. Effets du virus sur la cellule h
- Page 26 and 27:
VII. Physiopathologie de l’infect
- Page 28 and 29:
présence d’ADN de l’HHV-6 dans
- Page 30 and 31:
IX. 2. Infection des immunodéprim
- Page 32 and 33:
détails ultérieurement. De façon
- Page 34 and 35:
a b Figure 6 : Effet cytopathogène
- Page 36 and 37:
XI.1. Analogues nucléosidiques L
- Page 38 and 39:
Acyclovir (Zovirax ®) Valacyclovir
- Page 40 and 41:
Partie 2 : Le syndrome d’hypersen
- Page 42 and 43:
jours, et pouvant atteindre 38 à 4
- Page 44 and 45:
Carbamazépine, phénytoïne, valpr
- Page 46 and 47:
III. Implication virale Une étroit
- Page 48 and 49:
sus-citées (figure 11). Des travau
- Page 50 and 51:
La reconnaissance du syndrome le pl
- Page 52 and 53:
A B Figure 12 : Coupe histologique
- Page 54 and 55:
lymphome nodulaire est surtout fré
- Page 56 and 57:
maladie indolente avec des récidiv
- Page 58 and 59:
Facteurs associés à un pronostic
- Page 60 and 61:
Les cellules HRS présentent un imm
- Page 62 and 63:
IV.3. Dérégulation de l’express
- Page 64 and 65:
Figure 15 : Reprogrammation génét
- Page 66 and 67:
Un gain génétique est également
- Page 68 and 69:
transgéniques exprimant LMP1 déve
- Page 70 and 71: Références Méthode de détection
- Page 72 and 73: supprimer l’expression de la prot
- Page 74 and 75: Partie 1 : Etude du rôle de l’HH
- Page 76 and 77: Drogue Charge virale Figure 17 : D
- Page 78 and 79: Dilution du stock viral Volume de s
- Page 80 and 81: Acide valproïque Carbamazépine Ph
- Page 82 and 83: IV. Article 2 Amoxicillin-induced f
- Page 84 and 85: % viabilité cellulaire 140 120 100
- Page 86 and 87: VI. Etude d’une cohorte de patien
- Page 88 and 89: VII. Article 3 Drug Reaction with E
- Page 90 and 91: de monocytoses ou de lymphadénopat
- Page 92 and 93: Nombre de copie de EBNA1 (% contrô
- Page 94 and 95: injectées à des souris immunodép
- Page 96 and 97: Au sein du laboratoire de microbiol
- Page 98 and 99: égion V du gène des immunoglobuli
- Page 100 and 101: IV. Article 4 Involvement of human
- Page 102 and 103: I. Discussion des articles 4 et 5 L
- Page 104 and 105: Récepteur Cytoplasme Figure 24 : M
- Page 106 and 107: Conclusions - perspectives Ce trava
- Page 108 and 109: moindre importance. Il serait inté
- Page 110 and 111: perte relative du programme d’exp
- Page 112 and 113: d’orienter la recherche de déré
- Page 114 and 115: Alexander, F. E., Jarrett, R. F., L
- Page 116 and 117: D. V. & DiPaolo, J. A. (1994a). Hum
- Page 118 and 119: Lancet 2, 390. Dutton, A., Reynolds
- Page 122 and 123: in the IkappaBalpha gene in the mal
- Page 124 and 125: development in human germinal centr
- Page 126 and 127: (HHV-6) variant A from a parent to
- Page 128 and 129: Renne, C., Martin-Subero, J. I., Ei
- Page 130 and 131: y polymerase chain reaction in chil
- Page 132 and 133: Torlakovic, E., Tierens, A., Dang,
- Page 134 and 135: Young, L. S. & Murray, P. G. (2003)